Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | chloroquine | 36462 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | chloroquine | 36462 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | chloroquine | 36462 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | chloroquine | 36462 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | chloroquine | 36462 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | chloroquine | 36462 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | chloroquine | 36462 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | chloroquine | 36462 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | chloroquine | 36462 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | chloroquine | 36462 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | chloroquine | 36462 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | chloroquine | 36462 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | chloroquine | 36462 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | iobenguane | 2574 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | iobenguane | 2574 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | iobenguane | 2574 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | iobenguane | 2574 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | Prestwick-559 | None | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | Prestwick-559 | None | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | chlorcyclizine | 3442 | drug-path |